Maintaining relative humidity (RH) between 40% and 60% has been shown to significantly reduce the viability of airborne respiratory viruses, including influenza A and SARS-CoV-2, according to peer-reviewed research. The evidence is grounded in controlled laboratory studies and extended by real-world indoor research. Humidity is not a substitute for ventilation, filtration, or vaccination, but it is a controllable environmental variable with measurable effects on pathogen viability and aerosol behavior.
This article covers the mechanism behind that effect, the specific evidence for clinical pathogens, ASHRAE Standard 170-2021 compliance requirements, the infection control risks associated with certain humidifier technologies, and what healthcare facilities should look for in a system.
Key Takeaways
- Research by Noti et al., published in the Journal of Infectious Diseases, found that influenza viability dropped 70 to 77% when RH was maintained between 40% and 60%, compared to conditions below 23% RH.
- Enveloped viruses such as influenza A, SARS-CoV-2, and RSV are more sensitive to humidity-mediated destabilization than non-enveloped viruses, making humidity control most beneficial against the respiratory viruses most commonly transmitted in healthcare settings.
- ASHRAE Standard 170-2021 mandates specific RH ranges for healthcare occupancies by room type, and Joint Commission accreditation surveys evaluate environmental conditions including humidity, creating a regulatory obligation separate from infection control best practice.
- Evaporative and ultrasonic humidifiers can become reservoirs for Legionella pneumophila and Pseudomonas aeruginosa if maintenance schedules are not strictly observed, introducing a countervailing nosocomial infection risk.
- Precision humidification systems that produce self-evaporating droplets and operate without standing water reduce the microbial contamination risk associated with humidifier use in clinical environments.
- Specialized spaces such as negative-pressure isolation rooms and operating rooms carry additional ventilation and pressure constraints that govern how humidification systems can be integrated.
How Relative Humidity Affects Airborne Virus Survival
Three established mechanisms explain why RH affects viral behavior in indoor environments. Each operates independently, and their combined effect is what makes the 40 to 60% RH range meaningful for infection control planning.
- Hygroscopic aerosol growth: At higher RH, aerosol particles absorb moisture and increase in mass. Heavier particles settle out of the breathing zone faster, reducing the distance and duration of viable airborne transmission.
- Viral envelope destabilization: Humidity directly affects the lipid membranes of enveloped viruses. At moderate RH, these membranes degrade more rapidly, reducing pathogen viability before inhalation occurs.
- Mucociliary clearance support: Dry air impairs the mucociliary clearance system in the respiratory tract, reducing the body’s ability to expel inhaled aerosol particles. At 40 to 60% RH, mucociliary function operates more effectively, adding a host-defense dimension to the case for humidity control.
The Noti et al. study shows that influenza viability drops 70 to 77% at 40 to 60% RH. The Skanata et al. 2022 study, published in Environmental Science and Technology Letters, extended the mechanistic evidence from controlled chambers to real indoor environments, demonstrating that elevated humidity reduced both the speed and distance of viable aerosol dispersal using a bacteriophage surrogate in classroom settings.
Why Enveloped Viruses Are More Sensitive to Humidity
Enveloped viruses carry a lipid membrane surrounding their protein core. That membrane is more vulnerable to humidity-mediated chemical and physical degradation than the protein capsid of non-enveloped viruses. Influenza A, SARS-CoV-2, and RSV all belong to this category.
This distinction matters clinically. The respiratory viruses most commonly responsible for healthcare-associated airborne transmission are predominantly enveloped, meaning humidity control provides greater measurable benefit against the pathogens that drive the highest infection control burden in most clinical settings. Non-enveloped pathogens respond less predictably to RH changes and should not be assumed to follow the same pattern.
The Role of Mucociliary Clearance
The mucociliary clearance system is the respiratory tract’s primary mechanical defense against inhaled particles, including droplet nuclei carrying viable viral loads. In low-humidity environments, the mucus layer thins and ciliary function slows, reducing the efficiency of particle expulsion.
At optimal humidity levels in the 40 to 60% RH range, mucociliary clearance operates more effectively. This adds a host-defense dimension to the infection control argument for humidity management that goes beyond direct effects on viral survival, and it is particularly relevant in patient populations with compromised respiratory function.
What the Evidence Says: Key Studies on Humidity and Viral Transmission
The evidence base linking indoor RH to reduced airborne virus transmission spans controlled laboratory studies, clinical pathogen research, and real-world indoor measurements. No single study establishes definitive causation, but the collective body of research supports a consistent directional finding: moderate humidity reduces pathogen viability and limits the reach of viable aerosols.
Influenza: The Strongest Evidence Base
The Noti et al. study remains the most cited research in this domain for clinical audiences. The study used simulated cough aerosols in controlled humidity chambers to measure influenza A viability across RH conditions. At RH below 23%, influenza viability was high. When RH was maintained between 40% and 60%, viability dropped by 70 to 77%.
The study methodology, controlled chambers with simulated aerosols, provides a direct mechanism link rather than an epidemiological correlation. The research supports a specific operational target for facilities: maintaining 40 to 60% RH as an active infection control measure, not simply as a comfort parameter.
SARS-CoV-2 and Humidity: What Current Research Shows
SARS-CoV-2 is an enveloped virus, and the mechanisms governing influenza viability at higher RH apply similarly. Multiple research groups have found faster decay in viral viability at moderate RH compared to low-RH environments, though effect sizes vary by study design and aerosol generation method.
The evidence indicates that SARS-CoV-2 follows the same envelope-sensitivity pattern as influenza A, making the 40 to 60% RH target applicable. Humidity control is not a substitute for ventilation, filtration, or vaccination. The Skanata et al. 2022 classroom study using a bacteriophage surrogate extends these mechanistic findings into real indoor environments, showing that elevated humidity reduced rapid and distant dispersal of viable aerosol particles. The surrogate nature of the bacteriophage data should be noted: it extends the evidence base but does not directly measure SARS-CoV-2 behavior in clinical spaces.
ASHRAE 170-2021 and Regulatory Requirements for Healthcare Humidity
ASHRAE Standard 170-2021 specifies minimum and maximum relative humidity levels for specific clinical occupancies. The FGI Guidelines for Design and Construction of Hospitals reference these requirements for new construction and major renovation, creating a compliance obligation that extends beyond infection control best practice into building code.
The general patient room RH range under ASHRAE 170-2021 is 20 to 60% RH. Operating rooms carry the same humidity range with additional temperature constraints. The code-mandated minimum of 20% RH is not the same as the evidence-based optimal range of 40 to 60% RH, and understanding recommended humidity levels for hospitals is essential for facilities that want to move beyond mere compliance. Facilities that maintain only the minimum are code-compliant but are not operating within the range shown to reduce viral viability in the published literature.
Enforcement flows through Joint Commission accreditation surveys, which typically evaluate environmental conditions including humidity. Documented noncompliance can affect accreditation status. Many facilities chronically fall below even the minimum range during winter months, when mechanical heating drives indoor RH below 20%. This creates a simultaneous compliance and infection control risk that facilities managers must address through active humidity management, not passive HVAC operation.
The Gap Between Code Minimums and Evidence-Based Optimal Ranges
ASHRAE 170-2021 sets a minimum floor, not an operational target. The infection control literature consistently supports 40 to 60% RH as the functional target for reducing viral viability, which sits well above the 20% minimum in most patient care areas.
Facilities that calibrate humidity control to the code minimum are making a defensible compliance decision, but they are not capturing the infection control benefit that the research supports. For infection preventionists building the internal case for humidity investment, the distinction between the regulatory floor and the evidence-based optimal range is the argument. Holding 40 to 60% RH consistently requires a precision system, not a system tuned to avoid falling below 20%.
Humidity Considerations in Specialized Clinical Spaces
Negative-pressure isolation rooms, also called airborne infection isolation (AII) rooms, and operating rooms present additional constraints beyond general ward humidification. These spaces require specific air change rates and pressure differentials that affect how humidification systems can be integrated without disrupting designed airflow patterns.
Two considerations apply:
- AII rooms: maintaining negative pressure relative to adjacent corridors is a primary infection control requirement. Any humidification system introduced into these spaces must be compatible with the room’s ventilation design.
- Operating rooms: carry strict contamination control requirements that govern water-bearing systems.
Both space types require specialized engineering consideration, and standard humidification approaches designed for general patient areas aren’t automatically appropriate for deployment in them.
The Infection Control Risk of Improperly Maintained Humidifiers
Humidification in healthcare settings carries a countervailing risk that is well-documented but frequently absent from commercial content on this topic. Evaporative and ultrasonic humidifiers can harbor pathogenic organisms in their water reservoirs and on internal surfaces if maintenance schedules are not strictly observed.
Understanding how low humidity increases infection risk in healthcare environments alongside these equipment risks is essential for making sound humidification decisions.
The specific pathogens of concern include:
- Legionella pneumophila: Colonizes warm standing water in humidifier reservoirs and can be aerosolized directly into the breathing zone.
- Pseudomonas aeruginosa: A gram-negative opportunistic pathogen capable of colonizing humidifier water systems and presenting serious risk to immunocompromised patients.
- Fungal species: Including Aspergillus, which can establish in moist internal surfaces of improperly maintained systems and pose risk to oncology and transplant populations.
These risks do not mean humidification should be avoided in clinical settings. They mean the type of humidifier selected and its maintenance requirements are infection control decisions, not just operational ones. Hospital-acquired infections attributable to contaminated humidification equipment are documented in the clinical literature, and the governing guidance is specific.
What Governing Guidelines Require
CDC HICPAC Guidelines for Environmental Infection Control in Health-Care Facilities address humidifier selection and maintenance as part of the broader environmental infection control framework. ASHRAE Guideline 12 governs water system management including humidification equipment.
These are named standards with documented obligations, not theoretical risk frameworks. Facilities operating evaporative or ultrasonic systems in clinical areas without a written water management plan that addresses humidifier maintenance are out of alignment with both CDC HICPAC and ASHRAE Guideline 12 requirements. Infection preventionists and facilities engineers should treat humidifier selection as a water management decision governed by these standards.
Why System Design and Maintenance Interval Matter
Systems that operate with standing water reservoirs, wick systems, or ultrasonic transducers create recurring contamination risk windows. Each maintenance interval is a window during which the system operates with potentially colonized surfaces or water. More frequent maintenance demands mean more frequent risk windows, not safer operation.
Systems designed to eliminate standing water, to produce self-evaporating droplets that contact no surfaces, and to operate with extended maintenance intervals reduce the frequency of those risk windows by design. The infection control benefit of humidity control is meaningful only if the humidification system itself does not introduce a competing nosocomial risk. System architecture is the variable that determines whether humidification strengthens or undermines the infection control environment.
How Precision Humidification Systems Support Infection Control in Medical Facilities
Adiabatic humidification that produces an equal-sized droplet grid of self-evaporating droplets eliminates the standing water conditions that support microbial colonization in the humidification system itself. This is the engineering principle that addresses the contamination risk established in the preceding section. The droplets self-evaporate before reaching any surface, which means no moisture accumulates on surfaces, racks, ductwork, or equipment under proper system design.
Facilities considering healthcare facility humidification should evaluate this design characteristic as a primary selection criterion, and reviewing hospital-grade humidifiers can help decision-makers understand how different system architectures compare across clinical applications.
This is the operating principle behind Smart Fog’s industrial systems for hospital and clinic humidifiers. The non-wetting claim carries a caveat: surfaces placed directly in the fog stream will be wetted. The non-wetting performance applies to surfaces under proper system design, not to direct fog-stream exposure.
Non-Wetting Operation and the Case for Infection Control Environments
Non-wetting operation is not just a performance specification, it is an infection control requirement in clinical environments where surface moisture creates risk. Wet surfaces in patient care areas create conditions favorable to bacterial growth and present slip hazards and equipment damage risk. A humidification system that introduces moisture onto surfaces is not compatible with a clinical infection control program regardless of its effect on airborne viral viability.
For this reason, hospital humidity control for patient safety and infection prevention in clinical spaces must be evaluated against two simultaneous criteria: does the system maintain RH within the target range, and does it do so without introducing surface moisture or standing water that creates competing infection control risks? Both criteria must be satisfied for humidification to be a net positive in a clinical infection control program.
Precision adiabatic systems that produce uniform, self-evaporating droplets are engineered to meet both criteria simultaneously. Understanding what is relative humidity and how RH interacts with droplet behavior is foundational for facilities engineers specifying these systems in healthcare applications.
The contamination risks associated with standing-water systems, Legionella, Pseudomonas aeruginosa, and fungal colonization are structural risks tied to reservoir design, not risks that any single manufacturer’s claims can eliminate outright. Facilities evaluating a system should request documentation of maintenance interval, contamination testing protocols, and design features that eliminate standing water entirely.
Precision Within the Evidence-Based RH Range
Maintaining plus or minus 1 to 2% RH precision allows facilities to target 40 to 60% RH consistently, rather than cycling between the ASHRAE code minimum and the evidence-based optimal range. Consistent operation within that range is more defensible from an infection control standpoint than intermittent operation that drifts below or above the target band during HVAC cycling, occupancy changes, or seasonal shifts.
A system that swings between 25% and 55% RH may average within range but spends meaningful time outside the window where the research shows the greatest reduction in viral viability.
Final Thoughts
The evidence connecting relative humidity to airborne virus viability is specific, peer-reviewed, and increasingly cited in infection control literature: maintaining 40 to 60% RH measurably reduces the viability of enveloped respiratory viruses including influenza A and SARS-CoV-2, through mechanisms spanning aerosol physics, viral envelope stability, and host mucociliary defense. ASHRAE 170-2021 sets a regulatory floor, but that floor is not the same as the evidence-based target facilities should operate toward.
That evidence comes with an honest counterweight: the wrong humidifier technology can introduce a nosocomial infection risk of its own. Evaporative and ultrasonic systems with standing water reservoirs require rigorous maintenance discipline to avoid becoming a Legionella or Pseudomonas source. System architecture, not just the decision to humidify, determines whether a facility’s infection control posture improves or is compromised.
If a facility needs to maintain 40 to 60% RH consistently across clinical spaces without introducing the contamination risks associated with traditional humidification technologies, contact Smart Fog engineers to discuss a system designed for healthcare environments.
Consult a Humidity ExpertFAQ
What is the optimal relative humidity level to reduce airborne virus transmission in hospitals?
Peer-reviewed research supports 40 to 60% RH as the range most consistently associated with reduced viability of enveloped respiratory viruses, including influenza A and SARS-CoV-2. This is higher than the 20% minimum ASHRAE 170-2021 sets for many patient care areas, which is a regulatory floor, not an infection-control-optimized target.
Do humidifiers actually help prevent the spread of respiratory viruses in medical facilities?
Research indicates that maintaining 40 to 60% RH measurably reduces the viability and airborne dispersal of enveloped respiratory viruses. Humidity is not a substitute for ventilation, filtration, or vaccination, it is one control layer among several, and its benefit depends heavily on using a humidification system that doesn’t introduce its own contamination risk.
How does relative humidity affect the survival of influenza and SARS-CoV-2 indoors?
Both are enveloped viruses whose lipid membranes are more vulnerable to humidity-mediated degradation than the protein capsid of non-enveloped viruses. Noti et al. found influenza aerosol infectivity dropped from roughly 70–77% at low RH (≤23%) to roughly 15–22% at higher RH (≥43%). SARS-CoV-2 research generally shows a similar pattern, though effect sizes vary by study design.
What does ASHRAE Standard 170-2021 require for humidity in healthcare facilities?
ASHRAE 170-2021 sets minimum and maximum RH ranges by clinical occupancy type. General patient care areas require 30 to 60% RH; operating rooms carry a base floor of 20% RH, often raised to 30% procedurally. These figures are enforced indirectly through Joint Commission accreditation surveys and CMS Conditions of Participation.
Are there infection control risks associated with using humidifiers in hospitals?
Yes. Evaporative and ultrasonic humidifiers with standing water reservoirs can harbor Legionella pneumophila, Pseudomonas aeruginosa, and fungal species like Aspergillus if maintenance schedules aren’t strictly followed. This doesn’t mean humidification should be avoided, it means system design and maintenance discipline are infection control decisions, governed by CDC HICPAC guidance and ASHRAE Guideline 12.
Can humidifiers in medical facilities cause Legionella or other nosocomial infections?
Humidifiers with standing water reservoirs can become a Legionella or Pseudomonas source if not properly maintained. The risk is tied to system architecture, standing water and wick-based designs carry the highest exposure, while systems engineered to eliminate standing water entirely remove the reservoir condition these organisms need to colonize.
What type of humidifier is safest for use in a hospital or clinical environment?
Systems that produce self-evaporating droplets with no standing water reservoir, no wick, and extended maintenance intervals carry lower structural contamination risk than evaporative or ultrasonic designs. Facilities should request documentation of maintenance requirements and design features addressing standing water before procurement.
Is maintaining 40-60% RH enough to reduce airborne virus transmission, or are other measures required?
No single measure is sufficient. Humidity control is one layer among several, alongside ventilation, filtration, and vaccination. In specialized spaces like negative-pressure isolation rooms and operating rooms, humidification must also work within existing air change rate and pressure differential requirements, which adds engineering complexity beyond general ward humidification.
